Vaporization is a common delivery method for recreational cannabis in the North American market, but medical cannabis consumers in the Israeli and European markets are limited to flower and tinctures, according to Kanabo Founder, CEO, and Executive Director Avihu Tamir. Tamir launched Kanabo (LSE: KNB) to bring vaporization to the medical cannabis market. He spoke with New Cannabis Ventures about his company’s R&D work, listing on the London Stock Exchange and ramping up to generate revenue. The audio of the entire conversation is available at the end of this written summary. The Kanabo Team Israel developed one of the first federal medical cannabis programs in the late 1990s. In 2012, Tamir became a medical cannabis patient after his doctor recommended it as a way to manage his migraines. As a patient, Tamir had to learn how to roll joints. He previously wasn’t a smoker and started to think about different ways to consume the plant. Tamir first built a flower vaporizer distribution company in Israel. Next, he turned his eye to extracts and medical vaporization.

New Cannabis Ventures, 03/10/2021 12:34:00

Open article: